Subtype
Malignant Intestinal Neoplasm
CI-CAN-00001137Explore in graph →
1,666 active trials21 approved drugs383 evidence items
- NCIt
- C4572
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001137Explore in graph →
Clinical trials
7,773 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (772)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01763450 | Bevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal Cancer | unknown | Phase 2 | 100 | Liaoning Cancer Hospital & InstituteOTHER | 1 | Jan 29, 2013 | clinicaltrials |
| NCT00482222 | Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer | unknown | Phase 3 | 340 | University of SouthamptonOTHER | 1 | Jan 23, 2013 |
| NCT01761097 | Endocuff Adenoma Detection Rate Pilot Study | unknown | N/A | 300 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | Jan 8, 2013 | clinicaltrials |
| NCT01754272 | A Non-Interventional Follow-Up to the VELOUR Study - Translational Research | unknown | — | 1,226 | KU LeuvenOTHER | 19 | Dec 21, 2012 | clinicaltrials |
| NCT00610636 | Treatment Outcomes of Hepatic Metastasis After FOLFOX-4 Therapy | unknown | Phase 3 | 200 | National Taiwan University HospitalOTHER | 1 | Dec 10, 2012 | clinicaltrials |
| NCT01745874 | Diagnostic Value of Whole-Body MRI for Rectal Cancer Preoperative Staging | unknown | — | 20 | University of Lausanne HospitalsOTHER | 1 | Dec 10, 2012 | clinicaltrials |
| NCT00601549 | A Randomized Controlled Clinical Trial Comparing Oncological Results and Functional Recovery Between Laparoscopic and Open Method for the Treatment of Advanced Rectal Cancer After Concurrent Chemoradiation Therapy (CCRT) | unknown | Phase 3 | 600 | National Taiwan University HospitalOTHER | 1 | Dec 6, 2012 | clinicaltrials |
| NCT01744509 | PillCam Colon Capsule 2® (PCC2) in the Setting of Colorectal Cancer Screening Program | unknown | N/A | 35 | Valduce HospitalOTHER | 1 | Dec 6, 2012 | clinicaltrials |
| NCT01320319 | Effect of EPA on Aerobic Performance, Muscle, and Quality of Life in Colorectal Cancer Surgery Patients(EPA-colo) | unknown | Phase 2 / Phase 3 | 70 | University of NottinghamOTHER | 1 | Dec 4, 2012 | clinicaltrials |
| NCT01736904 | wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients | unknown | Phase 2 | 100 | Fudan UniversityOTHER | 1 | Nov 29, 2012 | clinicaltrials |
| NCT01227239 | Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting | unknown | Phase 1 / Phase 2 | 45 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Nov 27, 2012 | clinicaltrials |
| NCT01700283 | Developing Objective Fatigue Indicators in Colorectal Cancer Survivors. | unknown | N/A | 306 | National Taiwan University HospitalOTHER | 1 | Nov 14, 2012 | clinicaltrials |
| NCT00385970 | A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer | unknown | Phase 3 | 380 | Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment GroupOTHER | 1 | Oct 26, 2012 | clinicaltrials |
| NCT01655641 | Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery(TMGS) | unknown | Phase 2 / Phase 3 | 118 | Tribhuvan University Teaching Hospital, Institute Of Medicine.OTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT01707511 | The Investigation of the EtCO₂- PaCO₂ Relation During Laparoscopic Colon Surgery | unknown | — | 40 | Diskapi Teaching and Research HospitalOTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT01237665 | IXO (Irinotecan, Xeloda, Oxaliplatin) in Rectal Cancer(IXOr) | unknown | Phase 2 | 15 | Ottawa Hospital Research InstituteOTHER | 1 | Oct 15, 2012 | clinicaltrials |
| NCT01679327 | Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer | unknown | Phase 2 | 100 | Chinese Academy of Medical SciencesOTHER | 1 | Sep 6, 2012 | clinicaltrials |
| NCT01679756 | INtracorporeal Versus EXTracorpoREal anastoMOsis After Laparoscopic Right Colectomy for Cancer(INEXTREMO) | unknown | N/A | 384 | Ospedale Misericordia e DolceOTHER | 1 | Sep 6, 2012 | clinicaltrials |
| NCT01677728 | Effect of Target Therapy on Patients Undergoing Synchronic Hepatectomy for Colorectal Liver Metastases | unknown | — | 60 | Xu jianminOTHER | 1 | Sep 3, 2012 | clinicaltrials |
| NCT01671891 | Detection and Enumeration of Circulating Tumor Cells in Rectal Cancer | unknown | — | 100 | Fudan UniversityOTHER | 1 | Aug 24, 2012 | clinicaltrials |
| NCT00470951 | Randomized Prospective Trial for Laparoscopic vs Open Resection for Rectal Cancer(CTS-179) | unknown | Phase 3 | 340 | National Cancer Center, KoreaOTHER_GOV | 1 | Aug 17, 2012 | clinicaltrials |
| NCT00745927 | Application of CO2 Insufflations in Colonoscopy Randomized Trial | unknown | N/A | 400 | National Taiwan University HospitalOTHER | 1 | Aug 14, 2012 | clinicaltrials |
| NCT01653301 | Preoperative Downstaging of Extraperitoneal T3 Rectal Cancer: XELOXRT Versus XELACRT. A Multicenter, Phase III Study(INTERACT) | unknown | Phase 3 | 616 | Catholic University of the Sacred HeartOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT01636674 | 18F-FDG PET/CT and Molecular Tumor Characterisation for Staging and Follow-up of Colon Cancer(COLOPET1) | unknown | N/A | 66 | Naestved HospitalOTHER | 0 | Jul 10, 2012 | clinicaltrials |
| NCT01384994 | Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type Patients | unknown | Phase 2 | 111 | PD Dr. med. Volker HeinemannOTHER | 1 | Jul 9, 2012 | clinicaltrials |
| NCT01410760 | PERfusion CT in the FOXFIRE Trial to Study Blood Flow to Liver Metastases(PERFORM) | unknown | Early Phase 1 | 40 | University of OxfordOTHER | 1 | Jun 20, 2012 | clinicaltrials |
| NCT01610895 | Split Dose Polyethylene Glycol (PEG) + Clear Fluids Versus Split Dose PEG + Low-Residue Diet(BP) | unknown | N/A | 345 | University of CalgaryOTHER | 1 | Jun 4, 2012 | clinicaltrials |
| NCT01579591 | VSL#3 Versus Placebo in Increasing the Pathological Major Response Rate in Patients With Rectal Cancer | unknown | Phase 3 | 160 | Catholic University of the Sacred HeartOTHER | 1 | Apr 18, 2012 | clinicaltrials |
| NCT01214031 | Prospective Study for Evaluating Colon Polyp Histology With in Vivo Probe Based Confocal Laser Endomicroscopy | unknown | N/A | 70 | Midwest Biomedical ResearchOTHER | 1 | Apr 9, 2012 | clinicaltrials |
| NCT01566942 | FOLFIRI or mFOLFOX6 in Adjuvant Chemotherapy in Advanced Colorectal Cancer | unknown | Phase 3 | 200 | Sun Yat-sen UniversityOTHER | 1 | Mar 30, 2012 | clinicaltrials |
| NCT01552967 | Efficacy and Safety Study of a Modified XELOX Regimen in First-Line Treatment of Metastatic Colorectal Adenocarcinoma(mXELOX) | unknown | Phase 2 | 30 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Mar 28, 2012 | clinicaltrials |
| NCT00689702 | Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal Cancer(XERT) | unknown | Phase 2 | 43 | Institute of Oncology LjubljanaOTHER | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00842686 | Preoperative Radiotherapy With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer: CRAB Phase II Study(CRAB) | unknown | Phase 2 | 60 | Institute of Oncology LjubljanaOTHER | 1 | Mar 26, 2012 | clinicaltrials |
| NCT01152164 | Quality of Life in Patients After Combined Modality Treatment of Rectal Cancer | unknown | — | 167 | Institute of Oncology LjubljanaOTHER | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00666107 | Pilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-infected Men(MIRB #862) | unknown | N/A | 150 | Southern California Institute for Research and EducationOTHER | 1 | Mar 14, 2012 | clinicaltrials |
| NCT01064999 | A Trial of High Intensity Versus Low Intensity Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer | unknown | Phase 2 / Phase 3 | 240 | Fudan UniversityOTHER | 1 | Mar 14, 2012 | clinicaltrials |
| NCT01549067 | The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey(Sprit) | unknown | — | 3,700 | Chinese Medical Doctor AssociationOTHER | 1 | Mar 14, 2012 | clinicaltrials |
| NCT01527409 | The Efficacy of Health Partnership Program for Cancer Patients | unknown | N/A | 248 | National Cancer Center, KoreaOTHER_GOV | 1 | Feb 7, 2012 | clinicaltrials |
| NCT00777478 | Capiri-sutent Phase-1 in Advanced Colo-rectal Cancer(sutent-capiri) | unknown | Phase 1 | 32 | Radboud University Medical CenterOTHER | 1 | Feb 3, 2012 | clinicaltrials |
| NCT00122291 | A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer | unknown | Phase 2 | 66 | Alberta Health servicesOTHER | 1 | Jan 19, 2012 | clinicaltrials |
| NCT01311050 | A Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination With Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancer | unknown | — | 46 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Dec 13, 2011 | clinicaltrials |
| NCT01489332 | Induction Chemotherapy,Radiochemotherapy, Consolidation Chemotherapy in Preoperative Treatment of Rectal Cancer | unknown | Phase 2 | 60 | Institute of Oncology LjubljanaOTHER | 1 | Dec 9, 2011 | clinicaltrials |
| NCT01474187 | Genotype-driven Phase I Study of Irinotecan Administered in Neoadjuvant Chemoradiotherapy in Patients With Stage II/III Rectal Cancer | unknown | Phase 1 | 60 | Fudan UniversityOTHER | 1 | Nov 18, 2011 | clinicaltrials |
| NCT01464918 | Safety and Efficacy of Using MASTER to Perform Endoscopic Submucosal Dissection in Human | unknown | N/A | 7 | National University Hospital, SingaporeOTHER | 3 | Nov 4, 2011 | clinicaltrials |
| NCT01214681 | Chemoprevention of Colorectal Cancer: the Role of Non-digestible Carbohydrates | unknown | N/A | 75 | Newcastle UniversityOTHER | 1 | Oct 26, 2011 | clinicaltrials |
| NCT01459328 | Resource-Sparing Curative Treatment for Rectal Cancer | unknown | Phase 3 | 350 | International Atomic Energy AgencyOTHER_GOV | 11 | Oct 25, 2011 | clinicaltrials |
| NCT01048463 | Effect of Enteral Nutrition Rich in Eicosapentaenoic Acid (EPA) on Patients Receiving Chemotherapy for GI Tumor | unknown | Phase 3 | 90 | Sun Yat-sen UniversityOTHER | 1 | Oct 6, 2011 | clinicaltrials |
| NCT00931840 | A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma | unknown | Phase 2 | 220 | Enzon Pharmaceuticals, Inc.INDUSTRY | 5 | Sep 20, 2011 | clinicaltrials |
| NCT01292681 | Multi-modality Imaging in the Prediction of Response to Systemic Treatment in Colorectal Cancer | unknown | N/A | 60 | Radboud University Medical CenterOTHER | 1 | Sep 8, 2011 | clinicaltrials |
| NCT00438737 | Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer | unknown | Phase 2 | 100 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Sep 2, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Jan 29, 2013source: clinicaltrials